Daniel Barber

Daniel Barber is a declared insider of Aquestive Therapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). The record holds 16 filings, for trades running from 8 June 2022 to 15 October 2026.

The open-market side counts 1 purchase for €82k alongside 8 sales for €853k. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 7 share grants. 2026 to date brings no purchases and 6 sales.

The record was last updated on 16 October 2026 with an open-market sale (€94k) in Aquestive Therapeutics, Inc. The latest purchase dates back some time: it was published 1,591 days ago, on 10 June 2022. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.